Member Post


OK, it’s on now! HCQ vs Remdesivir. The American Journal of Epidemiology has accepted a manuscript by Dr. Harvey A Risch, Professor of Epidemiology in the Department of Epidemiology and Public Health at the Yale School of Public Health and Yale School of Medicine, entitled Early Outpatient Treatment of Symptomatic, High-Risk Covid-19 Patients that Should […]

Join Ricochet!

This is a members-only post on Ricochet's Member Feed. Want to read it? Join Ricochet’s community of conservatives and be part of the conversation. Get your first month free.

There are 19 comments.
But you can't read them because you're not signed in!

Become a member to read the comments and join the conversation. Or sign in if you're already a member.